Product Reports Resources Pricing Login Book a demo

Dr Lal PathLabs

Health Tech & Medtech · India · Founded 1949

The largest and most respected diagnostic service provider in India MoreLess

The story of Dr Lal PathLabs begins in 1949, a time of significant change in India. Dr. S.K. Lal, a pathologist trained in the British Indian Army, established a single pathology laboratory and blood bank in Delhi. He had a vision to provide authentic and reliable diagnostic services, a novel concept for a private enterprise at the time. The early years were focused on building a reputation for quality. A major turning point came in 1995 when the sole proprietorship was incorporated into a private limited company, setting the stage for structured growth. This was followed by a concerted effort to gain national and international accreditations in the early 2000s, solidifying its commitment to quality. In 2005, the company secured its first institutional investment from WestBridge Capital, which fueled a period of significant expansion, including strategic acquisitions. This growth trajectory continued, and in 2015, Dr Lal PathLabs launched its Initial Public Offering (IPO), getting listed on both the BSE and NSE. This event marked a new chapter for the company, providing capital for further nationwide expansion. Today, Dr Lal PathLabs operates a vast network of laboratories and patient service centers across India. The business functions on a hub-and-spoke model, with central reference labs supporting a wider network of regional and satellite centers to ensure efficiency and accessibility. Through strategic growth and a foundational commitment to quality, a single lab has transformed into a leading player in the Indian diagnostic landscape.

Company overview

Dr Lal PathLabs company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
1949
Headquarters
India
Employees
7,430
Open positions
20
Dealroom signal
55.6
Investment activity
2 companies · latest Nov 2022
Capital deployed
Preferred round
SEED
client focusb2bsub industryHealth PlatformsectorDiabetesindustryHealthsectorPerformance ManagementsectorOncologysectorPatient CaresectorPay Per Result

Valuation & funding

Dr Lal PathLabs funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
OtherOther financing Dec 2015 $29M JP Morgan · Reliance Capital · Fidelity Investments · State Bank of India
SEEDEquity / VC Aug 2010 $0 TA Associates
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMarginProfitMargin
2026 $375M +12.2% $116M 31% $69M 18.3%
2025 $334M +10.6% $107M 32.1% $66M 19.8%
2024 $302M +10.4% $91M 30% $49M 16.1%
2023 $274M -3.4% $72M 26.4%
2022 $283M +32% $83M 29.2%
2021 $215M +18.9% $66M 30.5%
2020 $181M $54M 29.7%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Dr Lal PathLabs website traffic

Latest recorded traffic for Dr Lal PathLabs is 2.2M monthly website visits, up 100% over the last three months. Dr Lal PathLabs's team grew 81.3% over the past year.

Latest monthly visits2.2M 3-month web change+100% 1-year team growth+81.3%
Monthly website visits48 observations · Jun 2015–Mar 2021
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Dr Lal PathLabs compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Datos HealthDatos is a provider of a hospital-grade oncology patient management platform designed to connect the medical source of care directly with the patient for improved quality of life New York City, United States Operational 38 $7M $28M
PodimetricsDevelops an early warning system to predict and prevent diabetic foot ulcers Somerville, United States Operational
Merck & Co.Merck develops and produces medicines, vaccines, biologic therapies and animal health products Kenilworth, United States Operational
MedivizorMedivizor (medivizor.com) seeks to improve the quality of lives of those facing serious or chronic medical conditions Ramat Gan, Israel Operational
HumaProvides a digital health platform used for predictive care and research London, United Kingdom Operational
Among DoctorsAn integrated and innovative digital service, enabling the professional development of doctors globally Municipality of Kifisia, Greece Operational
TreatoIdentifies, aggregates and analyzes user-generated content from across the social health Web, to generate "patient voice"​ insights that help drive health-related decisions for patients and providers alike Yehud Monosson, Israel Operational
Health CatalystTech platform that organizes and links health-related data from different systems and makes it available for all users South Jordan, United States Operational
Showing 8 of the closest matchesCompare every metric →

Talent graph

Dr Lal PathLabs's talent

Book a demo to see the people
Team profiled 25 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Dr Lal PathLabs's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
TA Associates
Other known 6 additional known investors
Birla Sun Life Insurance
Fidelity Investments
JP Morgan
Reliance Capital
State Bank of India
T. Rowe Price

Global footprint

Where Dr Lal PathLabs has talent and traffic

Workforce by country
12 countries with
team presence
🇮🇳 India97.9%
🇳🇵 Nepal0.5%
🇧🇩 Bangladesh0.3%
🇨🇦 Canada0.2%
🇦🇪 United Arab Emirates0.2%
Top 5 of 12 shown

In the news

Latest news about Dr Lal PathLabs

Recent press, funding announcements, and product moves mentioning Dr Lal PathLabs — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Dr Lal PathLabs

An AI-synthesized read of the highest-engagement posts about Dr Lal PathLabs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Dr Lal PathLabs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.